Alberta Premier Jason Kenney said the province is ready to move on to the next phase of its reopening plan on March 1, as the numbers of COVID-19 transmissions and hospitalizations “continue to decline rapidly.”
Some tests were found to contain the preservative sodium azide, a liquid reagent that can cause low blood pressure when ingested, resulting in dizziness, headaches or palpitations.
